SUMMARY Forty five patients with amyotrophic lateral sclerosis were investigated, by means of somatosensory evoked potentials, in order to detect the presence of subclinical sensory changes. Cervical SEPs from the median nerve and cortical SEPs from the median and tibial nerve were recorded, showing a delay of N1B and subsequent components; the latency of the first constant cortical potential was also increased in many patients. Only the SEPs from the tibial nerve showed a decrease of amplitude. These results suggest a pathological slowing of conduction along the central sensory pathways in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis is generally considered to be a system disease because of selective involvement of upper and lower motor neurons. Sensory disturbances characteristically are absent in typical amyotrophic lateral sclerosis, although cramps and paraesthesias may occur; nevertheless a certain number of detailed pathological studies have claimed to show the presence of changes in sensory nerve myelinated fibres, ' 2 in spinocerebellar pathways,3 Clarke's nucleus,4 posterior columns5 ' and thalamus.8 These changes have been reported more frequently in familial than in sporadic amyotrophic lateral sclerosis.9 A patient with a chronic pain syndrome associated with amyotrophic lateral sclerosis has recently been described.'0 In a series of investigations about the possible involvement of subsystems other than motor neurons in sporadic amyotrophic lateral sclerosis, we have examined somatosensory evoked potentials (SEPs) in 45 patients in an attempt to detect the presence of subclinical alterations.
Materials and methods
Forty five patients with amyotrophic lateral sclerosis ( The clinical picture of these patients were divided into: typical amyotrophic lateral sclerosis without bulbar signs, typical amyotrophic lateral sclerosis with bulbar signs, bulbar and pseudobulbar amyotrophic lateral sclerosis and amyotrophic lateral sclerosis with predominant lower motor neuron involvement (without pyramidal signs). The patients were further divided into three groups, according to the duration of the disease: I = up to 12 months, II = from 13 to 24 months, III = more than 24 months. The muscular impairment was classified as light, moderate or heavy, according to the clinical evaluation of the functional capacity. The tallness of the patients and the presence or the absence of cervical spondylosis on plain radiographs was also considered. These clinical features are shown in table 1.
The control cases, matched for age, sex and tallness were sampled from normal subjects of the laboratory. The patients, relaxed in an arm-chair, in a silent room, were requested to close their eyes. The stimulating electrodes were placed on the skin overlying the median nerve at the wrist and the tibial posterior nerve at the ankle; both sides were sometimes examined. The stimulus had a duration of 0-1 ms, a frequency of 3 Hz and an intensity of 20% above that required to induce a modest muscular twitch. The recording silver-silver chloride electrodes were placed at C3 or at C4-Fpz (cortical SEPs after stimulation of the median nerve), at Cz-Fpz (cortical SEPs after stimulation of the tibial nerve), according to the 10-20 International System and above 7th cervical spine (C7-Fpz) for cervical SEPs after stimulation of the median nerve. Electrode impedance was low, less than 3 kohm. Signals were amplified and averaged by a Neuroaverager OTEBiomedica 1239-512 words (bandpass 16-1000 Hz, bin-857 We observed that the N9 latency was increased in the group with spondylosis (9.8 ms + 0.8) as compared to the group without spondylosis (9.1 ms 0.9) (t = 2-45; p < 0.02). The N1l latency was 12 
Discussion
The measurement of cervical and cortical SEPs allows the recognition of subclinical sensory disturbances and their localisation along the afferent pathways; considerable progress has been made recently in the description and investigation of the potentials' pattern and sources'1-16 and their alterations in different neurological diseases. 7'-9 In amyotrophic lateral sclerosis somatosensory cortical evoked potentials were investigated by Dustman20 who observed significant reduction of the peaks' amplitudes and a trend toward increased latencies. Visual evoked potentials (VEPs) were found to be normal.20 Somatosensory evoked potentials were also abnormal in 62-5% and 34% of patients with amyotrophic lateral sclerosis at lower and upper limbs respectively according to Matheson2' and in one out of three cases according to Anziska.22 A lower percentage of patients (12%) displayed abnormal visual and brain-stem evoked potentials. 2' Our results confirm that SEPs may be clearly abnormal in certain amyotrophic lateral sclerosis patients: the main abnormality is a significant delay of N13 and subsequent components while the amplitudes are relatively preserved. Only SEPs from the tibial nerve showed a significant decrease of amplitude. Cortical SEPs showed a generally normal waveform but the latency of the first negative (N19) component was clearly increased. So the main pathological alteration was a slowing of conduction along the sensory pathways.
We think that the level of the sensory involvement is most probably localised within the dorsal columns and the lemniscal pathways. The presence of normal amplitude and latency of N9 indicates that a normal afferent volley has been conducted along the brachial plexus after the stimulation, without any delay; abnormalities of N9 were found only in presence of lesions of the peripheral nerves. '9 Moreover the conduction velocity of the sensory fibres was in the normal range in those subjects in whom it was measured.
Cosi, Poloni, Mazzini, Callieco N11, which is considered to be generated near the spinal cord entry zone, '3 '5 '9 also displayed a normal latency. This fact, as well as the Ng-NH interval that was normal, seems to indicate that the roots were well preserved, at least in the subjects without cervical spondylosis; on the contrary, when spondylosis was present, the development of N 1I potential was delayed and the N9-N11 interval was increased. Growing evidence supports the notion that the N13 potential is generated rostrally, in the nucleus of the dorsal columns;'3 4 18 N13 appears constantly affected in patients with lesions of the cervical cord, caused by severe cervical myelopathy due to spondylosis. '9 Hence the increased latency of N13 and consequently the increased N 1-N13 and N9-N13 intervals suggest a slowing of conduction in the dorsal columns; on the other hand the increase of the so called central conduction time, that is, the N13-N19 interval, seems to indicate a delayed conduction of afferent potentials also along the lemniscal pathways up the cortex. Moreover these disturbances of the somatosensory system, clearly shown in amyotrophic lateral sclerosis, seem to progress with increasing duration and severity of the disease, as it was also indicated in the work by Dustman.20 The possibility exists that these delayed evoked responses in amyotrophic lateral sclerosis might be dependent on the pathological lesions affecting the afferent pathways, recognised in necropsy studies by Charcot and Marie6 in 1885 and Holmes,3 and more recently confirmed.458 Alternatively they might be due to a loss of the pyramidal feedback acting on the somatosensory pathways and specifically on the dorsal horns, as recently suggested20 on the basis of the well known relationships between the afferent and efferent systems.
Interestingly it has been recently shown that choline acetyltransferase activity is severely reduced in the spinal cord of patients with amyotrophic lateral sclerosis not only in the ventral horns, where it is associated with motor neurons, but also in the apical area of the dorsal horns,23 the site of the spinal interneurons: this finding gives a biochemical substrate to the morphological degeneration of Clarke's nucleus.4
The sensory system could therefore be affected by the same abnormality involving the motor neurons, but to a lesser extent and without clinical evidence.' in amyotrophic lateral sclerosis. 
Somatosensory evoked potentials

